Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Vote in favor of Your #1 Climbing boots Now - 2Tasting America: An Excursion Through Darling Cheap Food Brands
- 3Luigi Mangione‘s lawyers say Bondi’s death penalty decision was tainted by conflict of interest
- 4Choosing the Ideal Bed for Quality Rest and Solace
- 5Native artists in Texas and Mexico shared their vision of the universe for 4,000 years, ancient murals suggest
- Famous Places to get-away for Americans
- Flu cases skyrocket in US. See cases, where people got sick.
- A Manual for Nations with Extraordinary Food
- Pilot captures jaw-dropping northern lights show from 36,000 feet (photos)
- See the metal guts of a satellite in this wild X-ray view | Space photo of the day for Dec. 4, 2025
- The 20 Most sultry Style of the Time
- The most effective method to Remain Ahead in the Most recent Advanced Patterns with a Web based Advertising Degree
- New hybrid mpox strain discovered in UK after US reports local spread
- Best Amusement Park Bite: What Do You Very much want to Crunch On?
